| Title | Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia |
|---|---|
| Disease/Condition | Heart and Vascular Diseases |
| Description | |
| Eligibility Criteria | Ages Eligible for Study: up to 18 Years (Child, Adult) Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
| Principal Investigator | Scott Aydin,MD |
| Contact Name | Helen Alexander, RN |
| Phone | (718) 741-2678 |
| Contact Email | healexan@montefiore.org |
| Protocol Number | IRB# 15-08-314 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | Yes |
| Adult, Pediatric, Both | Pediatric |